0001093557-16-000548.txt : 20160526
0001093557-16-000548.hdr.sgml : 20160526
20160526202954
ACCESSION NUMBER: 0001093557-16-000548
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160525
FILED AS OF DATE: 20160526
DATE AS OF CHANGE: 20160526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOLETTA MARK G
CENTRAL INDEX KEY: 0001236389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 161679809
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS INC
STREET 2: 9360 TOWNE CENTRE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-05-25
0
0001093557
DEXCOM INC
DXCM
0001236389
FOLETTA MARK G
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2016-05-25
4
A
0
5450.0
0.0010
A
17443
D
Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
Included in this number are 14,698 unvested restricted stock units, 5,450 of which were granted on May 25, 2016 and shall vest on May 25, 2017, 4,671 of which were granted on June 3, 2015 and shall vest on June 3, 2016 and 4,577 unvested restricted stock units granted on November 17, 2014 and shall vest through November 17, 2017.
By: John Lister For: Mark G. Foletta
2016-05-26